170 related articles for article (PubMed ID: 17971944)
1. [Predictive factors of hepatitis B virus DNA negative conversion among patients with chronic hepatitis B during lamivudine therapy].
Chen JL; Wang L; Yan J; Zhang L; Yu H; Fan XL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):273-5. PubMed ID: 17971944
[TBL] [Abstract][Full Text] [Related]
2. [Occurrence and predictive factors of hepatitis B virus polymerase YMDD variation among patients with chronic hepatitis B and liver cirrhosis during lamivudine therapy].
Wang L; Yan J; Zhang ZH; Wang JB; Du YZ; Li XY; Wang YZ
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):585-8. PubMed ID: 15504286
[TBL] [Abstract][Full Text] [Related]
3. Precore stop codon mutation of hepatitis B virus is associated with low breakthrough rate following long-term lamivudine therapy.
Shin JW; Chung YH; Choi MH; Kim JA; Ryu SH; Jang MK; Kim IS; Park NH; Lee HC; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2005 Jun; 20(6):844-9. PubMed ID: 15946130
[TBL] [Abstract][Full Text] [Related]
4. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
Dai CY; Chuang WL; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Huang JF; Hsieh MY; Wang LY; Tsai JF; Wen-Yu ; Yu ML
Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
[TBL] [Abstract][Full Text] [Related]
5. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B.
Villeneuve JP; Condreay LD; Willems B; Pomier-Layrargues G; Fenyves D; Bilodeau M; Leduc R; Peltekian K; Wong F; Margulies M; Heathcote EJ
Hepatology; 2000 Jan; 31(1):207-10. PubMed ID: 10613747
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudine-treated patients with chronic hepatitis B.
Feng B; Wei L; Chen M; Wang L
Microbiol Res; 2008; 163(4):487-92. PubMed ID: 17317127
[TBL] [Abstract][Full Text] [Related]
7. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
Yuen MF; Fung J; Seto WK; Wong DK; Yuen JC; Lai CL
Antivir Ther; 2009; 14(5):679-85. PubMed ID: 19704171
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with response to lamivudine: Retrospective study in a tertiary care clinic serving patients with chronic hepatitis B.
Hann HW; Jonsson Funk ML; Rosenberg DM; Davis R
J Gastroenterol Hepatol; 2005 Mar; 20(3):433-40. PubMed ID: 15740489
[TBL] [Abstract][Full Text] [Related]
9. [The prospective study of the clinical features and outcome of HBeAg-negative and HBeAg-positive cirrhosis in patients with chronic type B hepatitis].
Ma H; Guo F; Wei L; Sun Y; Wang H
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1832-5. PubMed ID: 17922993
[TBL] [Abstract][Full Text] [Related]
10. Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation.
Dai CY; Yu ML; Hsieh MY; Lee LP; Hou NJ; Huang JF; Chen SC; Lin ZY; Hsieh MY; Wang LY; Tsai JF; Chang WY; Chuang WL
Liver Int; 2007 Dec; 27(10):1364-70. PubMed ID: 17900250
[TBL] [Abstract][Full Text] [Related]
11. Lamivudine treatment in patients with hepatitis B virus induced liver cirrhosis.
Cetin K; Sabahattin K; Kadir D; Ahmet D; Ziyaettin D; Selim B; Mürüvvet B; Fatih B; Güngör B; Zeynel M; Yilmaz C; Atilla O
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxcv-ccxcvii. PubMed ID: 15244206
[TBL] [Abstract][Full Text] [Related]
12. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
Enomoto M; Tamori A; Kohmoto MT; Morikawa H; Habu D; Sakaguchi H; Takeda T; Seki S; Kawada N; Shiomi S; Nishiguchi S
J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
[TBL] [Abstract][Full Text] [Related]
13. Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C.
Kobayashi M; Suzuki F; Akuta N; Suzuki Y; Arase Y; Ikeda K; Hosaka T; Sezaki H; Kobayashi M; Iwasaki S; Sato J; Watahiki S; Miyakawa Y; Kumada H
J Med Virol; 2006 Oct; 78(10):1276-83. PubMed ID: 16927289
[TBL] [Abstract][Full Text] [Related]
14. Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance.
Hsu CW; Yeh CT; Chang ML; Liaw YF
Gastroenterology; 2007 Feb; 132(2):543-50. PubMed ID: 17258721
[TBL] [Abstract][Full Text] [Related]
15. [One year and half treatment with lamivudine in active cirrhosis resulting from chronic hepatitis B].
Zeng WQ; Guo SH; Zhang DZ; Zhou Z; Ren H; Zhang QH; Wang ZY
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):176-8. PubMed ID: 12681069
[TBL] [Abstract][Full Text] [Related]
16. [Week 24 suppression of HBV in entecavir-treated chronic hepatitis B patients in whom lamivudine treatment failed is associated with efficacy at week 48].
Ma H; Ren JB; Li HY; Wang Y; Wang RL; Liang L; Sun SJ; Jia JD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):102-4. PubMed ID: 17653304
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of spontaneous decline of HBV DNA in chronic hepatitis B patients in 12 weeks].
He H; Xu ZN; Cai DC; Nai N; Ling N; Zeng WQ; Shi XF; Zhao YR; Zhou Z; Zhang DZ
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):271-4. PubMed ID: 19403025
[TBL] [Abstract][Full Text] [Related]
18. [Detection of the mutation in HBV polymerase gene by RFLP PCR method in hepatitis B patients treated with lamivudine].
Li Z; Guo YB; Hao W; Lin ZH; Jin HY; Liu DG
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):266-9. PubMed ID: 15340574
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing outcome of lamivudine in anti-HBe-positive chronic hepatitis B.
Ascione A; Ascione T; Lanza AG; Utech W; Di Costanzo GG; Macri M
Hepatogastroenterology; 2006; 53(72):919-23. PubMed ID: 17153453
[TBL] [Abstract][Full Text] [Related]
20. [Application of serum hepatitis B virus large surface protein determination in lamivudine anti-viral therapy for patients with hepatitis B].
Li GY; Sheng JL; Huang HJ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):133-5. PubMed ID: 18574538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
